These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27933181)

  • 1. What are the pros and cons of electronically monitoring inhaler use in asthma? A multistakeholder perspective.
    Howard S; Lang A; Sharples S; Shaw D
    BMJ Open Respir Res; 2016; 3(1):e000159. PubMed ID: 27933181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence monitoring and e-health: how clinicians and researchers can use technology to promote inhaler adherence for asthma.
    Chan AH; Reddel HK; Apter A; Eakin M; Riekert K; Foster JM
    J Allergy Clin Immunol Pract; 2013; 1(5):446-54. PubMed ID: 24565615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using electronic monitoring devices to measure inhaler adherence: a practical guide for clinicians.
    Chan AH; Harrison J; Black PN; Mitchell EA; Foster JM
    J Allergy Clin Immunol Pract; 2015; 3(3):335-49.e1-5. PubMed ID: 25840665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asthma and COPD. Inhalation therapy--clarity or confusion?
    Seeto L; Lim S
    Aust Fam Physician; 2001 Jun; 30(6):557-61. PubMed ID: 11458583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refinement of an instrument to evaluate parental attitudes about follow-up care after an acute emergency department visit for asthma.
    Smith SR; Highstein GR; Jaffe DM; Fisher EB; Strunk RC
    J Asthma; 2005 Sep; 42(7):587-92. PubMed ID: 16169794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating the use of patient-reported outcomes for both clinical practice and performance measurement: views of experts from 3 countries.
    Van Der Wees PJ; Nijhuis-Van Der Sanden MW; Ayanian JZ; Black N; Westert GP; Schneider EC
    Milbank Q; 2014 Dec; 92(4):754-75. PubMed ID: 25492603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motivation for change and the pros and cons of smoking in a Spanish population.
    Font-Mayolas S; Planes M; Gras MA; Sullman MJ
    Addict Behav; 2007 Jan; 32(1):175-80. PubMed ID: 16647213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in patient reports of communications to inform decision making in the DECISIONS survey.
    Zikmund-Fisher BJ; Couper MP; Fagerlin A
    Patient Educ Couns; 2012 May; 87(2):198-205. PubMed ID: 21890299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying Subgroups among Hardcore Smokers: a Latent Profile Approach.
    Bommelé J; Kleinjan M; Schoenmakers TM; Burk WJ; van den Eijnden R; van de Mheen D
    PLoS One; 2015; 10(7):e0133570. PubMed ID: 26207829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of knowledge of asthma and inhaler devices in pharmacy workers.
    Gemicioglu B; Borekci S; Can G
    J Asthma; 2014 Nov; 51(9):982-8. PubMed ID: 24856971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.
    Coons SJ; Gwaltney CJ; Hays RD; Lundy JJ; Sloan JA; Revicki DA; Lenderking WR; Cella D; Basch E;
    Value Health; 2009 Jun; 12(4):419-29. PubMed ID: 19900250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging technologies for electronic monitoring of adherence, inhaler competence, and true adherence.
    Pritchard JN; Nicholls C
    J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):69-81. PubMed ID: 25548863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usage and usability of one dry powder inhaler compared to other inhalers at therapy start: an open, non-interventional observational study in Poland and Germany.
    Hantulik P; Wittig K; Henschel Y; Ochse J; Vahteristo M; Rytila P
    Pneumonol Alergol Pol; 2015; 83(5):365-77. PubMed ID: 26378998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do healthcare professionals understand asthma devices?
    Goodwin R; Heraghty J
    Arch Dis Child Educ Pract Ed; 2015 Dec; 100(6):302-5. PubMed ID: 26407731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could interchangeable use of dry powder inhalers affect patients?
    Price D; Summers M; Zanen P
    Int J Clin Pract Suppl; 2005 Dec; (149):3-6. PubMed ID: 16279996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pros and cons of prognostic disclosure to Japanese cancer patients and their families from the family's point of view.
    Yoshida S; Shiozaki M; Sanjo M; Morita T; Hirai K; Tsuneto S; Shima Y
    J Palliat Med; 2012 Dec; 15(12):1342-9. PubMed ID: 23151232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of expired and empty quick-relief asthma inhalers: The Asthma and Allergy Foundation of America's Asthma Inhaler Design Survey.
    Storms WW; Tringale M; Ferro TJ
    Allergy Asthma Proc; 2015; 36(4):300-5. PubMed ID: 25916212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001.
    Acquadro C; Berzon R; Dubois D; Leidy NK; Marquis P; Revicki D; Rothman M;
    Value Health; 2003; 6(5):522-31. PubMed ID: 14627058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and opportunities in respiratory drug delivery devices.
    Nikander K
    Expert Opin Drug Deliv; 2010 Nov; 7(11):1235-8. PubMed ID: 20939686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpreting clinical trial results of patient-perceived onset of effect in asthma: methods and results of a Delphi panel.
    Harding G; Leidy NK; Meddis D; Kleinman L; Wagner S; O'Brien CD
    Curr Med Res Opin; 2009 Jun; 25(6):1563-71. PubMed ID: 19445651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.